Glenview Capital Management’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-184,500
Closed -$55.2M 48
2023
Q4
$55.2M Sell
184,500
-60,000
-25% -$17.5M 1.18% 24
2023
Q3
$69.9M Hold
244,500
1.58% 25
2023
Q2
$68.6M Buy
+244,500
New +$63.7M 1.55% 21
2023
Q1
Sell
-200,000
Closed -$66.3M 58
2022
Q4
$66.3M Hold
200,000
1.47% 21
2022
Q3
$55.5M Hold
200,000
1.39% 20
2022
Q2
$52.7M Buy
200,000
+100,000
+100% +$25.8M 1.32% 24
2022
Q1
$24M Buy
+100,000
New +$23.4M 0.49% 41
2021
Q1
Sell
-200,000
Closed -$41.6M 67
2020
Q4
$41.6M Buy
+200,000
New +$39.2M 0.95% 31
2019
Q1
Sell
-250,000
Closed -$47.5M 49
2018
Q4
$47.5M Hold
250,000
0.46% 41
2018
Q3
$52.1M Buy
+250,000
New +$46.3M 0.33% 53

Other funds holding CI

Glenview Capital Management's CI Position: Q1 2026 in Review

Glenview Capital Management increased its Cigna (CI) stake by 79% in Q1 2026, buying an estimated $60.7M and bringing the position to 498,841 shares worth $133M. The position accounts for 3.34% of the portfolio, ranked #7.

Glenview Capital Management first reported a position in CI in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.02B in Q4 2015. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Glenview Capital Management held 498,841 shares of Cigna worth $133M as of Q1 2026.
  • Glenview Capital Management bought 219,474 Cigna shares in Q1 2026, an estimated $60.7M.
  • Cigna made up 3.34% of Glenview Capital Management's portfolio in Q1 2026, its #7 holding.
  • Glenview Capital Management first reported a position in Cigna in Q2 2013 and has held it in 52 quarters since.
  • Glenview Capital Management's Cigna position peaked at $1.02B in Q4 2015.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Glenview Capital Management's 13F filing for Q1 2026, filed 15 May 2026.